Document Detail

Pharmacotherapy in congestive heart failure: Vasopeptidase inhibition and its role in congestive heart failure.
MedLine Citation:
PMID:  12029184     Owner:  NLM     Status:  Publisher    
Vasopeptidase inhibition--that is, the dual inhibition of ACE and neutral endopeptidase-reduces blood pressure in a potent manner. Preliminary studies suggest that vasopeptidase inhibition can also effectively treat congestive heart failure. Additional corroborating studies to support the use of vasopeptidase inhibition in heart failure are now underway. (c)2000 by CHF, Inc.
D A Sica
Related Documents :
1791094 - Extreme axis deviation in a nigerian with severe congestive cardiac failure: an unusual...
8398034 - Pharmacologic treatment of acute congestive heart failure resulting from left ventricul...
1490944 - Energy status of the rapidly paced canine myocardium in congestive heart failure.
7691044 - Primary left atrial myxosarcoma.
21924584 - Oral treatment with nicorandil at discharge is associated with reduced mortality after ...
22633434 - Relation between poststenting peristent plaque components and late stent malapposition ...
Publication Detail:
Journal Detail:
Title:  Congestive heart failure (Greenwich, Conn.)     Volume:  6     ISSN:  1751-7133     ISO Abbreviation:  Congest Heart Fail     Publication Date:    2000 May-Jun
Date Detail:
Created Date:  2002-May-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9714174     Medline TA:  Congest Heart Fail     Country:  -    
Other Details:
Languages:  ENG     Pagination:  158-163     Citation Subset:  -    
Division of Clinical Pharmacology and Hypertension, Medical College of Virginia of Virginia Commonwealth University, Richmond, VA 23298.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Are all beta blockers the same for heart failure?
Next Document:  Difficult cases in heart failure: Bridge to beta blockade in severe heart failure: the use of phosph...